Vogelson, Cullen T <br/><br/>
Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.  [electronic resource] 

 -  Allergy and asthma proceedings   
 - 69-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1088-5412 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Adult<br/>Aged<br/>Allergens--adverse effects<br/>Animals<br/>Anti-Allergic Agents--administration & dosage<br/>Capillary Permeability--drug effects<br/>Circadian Rhythm--drug effects<br/>Conjunctivitis, Allergic--drug therapy<br/>Dibenzoxepins--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Guinea Pigs<br/>Histamine H1 Antagonists--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Olopatadine Hydrochloride<br/>Ophthalmic Solutions<br/>Severity of Illness Index<br/>Treatment Outcome